SurgiAI
AI-based Navigation System Automatically Detects Anatomical Structures Images During the Surgery
Company Overview
Snapshot
Founded in January 2023 by Noam Racheli, SurgiAI operates with 1–10 employees. The company has raised $800K across one funding round from two investors. In September 2024, SurgiAI secured seed funding, with eHealth Ventures participating as a lead investor.
Business overview
SurgiAI develops a platform for real-time tissue detection and tracking, providing surgeons with a precise and accurate navigation system for use during surgery. The company's core technology focuses on AI-based navigation to automatically detect anatomical structures in images during surgical procedures. SurgiAI operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare, clinical workflow, medical decision support, and medical devices markets.
Company Intelligence Q&A
- When was SurgiAI founded?
- SurgiAI was founded in January 2023.
- Who is the founder of SurgiAI?
- Noam Racheli is the co-founder and CEO of SurgiAI.
- What is SurgiAI's primary sector?
- SurgiAI's primary sector is Health Tech & Life Sciences.
- What is SurgiAI's core product?
- SurgiAI develops an AI-based navigation system that automatically detects anatomical structures in images during surgery, providing real-time tissue detection and tracking.
- What was SurgiAI's last funding event?
- In September 2024, SurgiAI secured seed funding, with eHealth Ventures participating as a lead investor and Israel Innovation Authority also investing.